86 related articles for article (PubMed ID: 16009335)
1. Endothelin inhibition delays onset of hyperglycemia and associated vascular injury in type I diabetes: evidence for endothelin release by pancreatic islet beta-cells.
Ortmann J; Nett PC; Celeiro J; Traupe T; Tornillo L; Hofmann-Lehmann R; Haas E; Frank B; Terraciano LM; Barton M
Biochem Biophys Res Commun; 2005 Aug; 334(2):689-95. PubMed ID: 16009335
[TBL] [Abstract][Full Text] [Related]
2. Transcriptional regulation of vascular bone morphogenetic protein by endothelin receptors in early autoimmune diabetes mellitus.
Nett PC; Ortmann J; Celeiro J; Haas E; Hofmann-Lehmann R; Tornillo L; Terraciano LM; Barton M
Life Sci; 2006 Apr; 78(19):2213-8. PubMed ID: 16300798
[TBL] [Abstract][Full Text] [Related]
3. Impaired vascular function in normoglycemic mice prone to autoimmune diabetes: role of nitric oxide.
Traupe T; Nett PC; Frank B; Tornillo L; Hofmann-Lehmann R; Terracciano LM; Barton M
Eur J Pharmacol; 2007 Feb; 557(2-3):161-7. PubMed ID: 17182032
[TBL] [Abstract][Full Text] [Related]
4. Acceleration of the development of diabetes in obese diabetic (db/db) mice by nicotinamide: a comparison with its antidiabetic effects in non-obese diabetic mice.
Piercy V; Toseland CD; Turner NC
Metabolism; 2000 Dec; 49(12):1548-54. PubMed ID: 11145115
[TBL] [Abstract][Full Text] [Related]
5. Downregulation of renal endothelin-converting enzyme 2 expression in early autoimmune diabetes.
Ortmann J; Nett PC; Celeiro J; Hofmann-Lehmann R; Tornillo L; Terracciano LM; Barton M
Exp Biol Med (Maywood); 2006 Jun; 231(6):1030-3. PubMed ID: 16741043
[TBL] [Abstract][Full Text] [Related]
6. Expression and regulation of osteopontin in type 1 diabetes.
Gong Q; Chipitsyna G; Gray CF; Anandanadesan R; Arafat HA
Islets; 2009; 1(1):34-41. PubMed ID: 21084847
[TBL] [Abstract][Full Text] [Related]
7. Autoimmune-mediated oxidative stress and endothelial dysfunction: implications of accelerated vascular injury in type I diabetes.
Zimmerman MA; Flores SC
J Surg Res; 2009 Jul; 155(1):173-8. PubMed ID: 18805553
[TBL] [Abstract][Full Text] [Related]
8. Essential role for signal transducer and activator of transcription-1 in pancreatic beta-cell death and autoimmune type 1 diabetes of nonobese diabetic mice.
Kim S; Kim HS; Chung KW; Oh SH; Yun JW; Im SH; Lee MK; Kim KW; Lee MS
Diabetes; 2007 Oct; 56(10):2561-8. PubMed ID: 17620422
[TBL] [Abstract][Full Text] [Related]
9. Extracellular matrix distribution and islet morphology in the early postnatal pancreas: anomalies in the non-obese diabetic mouse.
Geutskens SB; Homo-Delarche F; Pleau JM; Durant S; Drexhage HA; Savino W
Cell Tissue Res; 2004 Dec; 318(3):579-89. PubMed ID: 15480796
[TBL] [Abstract][Full Text] [Related]
10. E2F-1-deficient NOD/SCID mice developed showing decreased saliva production.
Matsui-Inohara H; Uematsu H; Narita T; Satoh K; Yonezawa H; Kuroda K; Ito T; Yoneda S; Kawarai T; Sugiya H; Watanabe H; Senpuku H
Exp Biol Med (Maywood); 2009 Dec; 234(12):1525-36. PubMed ID: 19934373
[TBL] [Abstract][Full Text] [Related]
11. ACE-inhibition ameliorates vascular reactivity and delays diabetes outcome in NOD mice.
Bucci M; Roviezzo F; Brancaleone V; Di Lorenzo A; Evangelista S; Gori M; Cirino G
Vascul Pharmacol; 2008; 49(2-3):84-90. PubMed ID: 18606247
[TBL] [Abstract][Full Text] [Related]
12. Islet expression of M3 uncovers a key role for chemokines in the development and recruitment of diabetogenic cells in NOD mice.
Martin AP; Grisotto MG; Canasto-Chibuque C; Kunkel SL; Bromberg JS; Furtado GC; Lira SA
Diabetes; 2008 Feb; 57(2):387-94. PubMed ID: 18003753
[TBL] [Abstract][Full Text] [Related]
13. Alterations in redox homeostasis and prostaglandins impair endothelial-dependent vasodilation in euglycemic autoimmune nonobese diabetic mice.
Ling X; Cota-Gomez A; Flores NC; Hernandez-Saavedra D; McCord JM; Marecki JC; Haskins K; McDuffie M; Powers K; Kench J; Oka M; McMurtry I; Flores SC
Free Radic Biol Med; 2005 Oct; 39(8):1089-98. PubMed ID: 16198235
[TBL] [Abstract][Full Text] [Related]
14. Hyperplastic islets observed in "reversed" NOD mice treated without hematopoietic cells.
Okubo Y; Shimada A; Kanazawa Y; Shigihara T; Oikawa Y; Imai T; Miyazaki J; Itoh H
Diabetes Res Clin Pract; 2008 Jan; 79(1):18-23. PubMed ID: 17919765
[TBL] [Abstract][Full Text] [Related]
15. Immunohistochemical study of the pancreatic basement membrane in non obese diabetic mice (NOD) with spontaneous autoimmune insulitis.
Pavin EJ; Pinto GA; Zollner RL; Vassallo J
J Submicrosc Cytol Pathol; 2003 Jan; 35(1):25-7. PubMed ID: 12762648
[TBL] [Abstract][Full Text] [Related]
16. Persistence of residual beta cells and islet autoimmunity during increasing duration of diabetes in NOD mice and experimental approaches toward reversing new-onset disease with bioactive peptides.
Reddy S; Cheung CC; Chai RC; Rodrigues JA
Ann N Y Acad Sci; 2008 Dec; 1150():171-6. PubMed ID: 19120289
[TBL] [Abstract][Full Text] [Related]
17. [Effects of pravastatin in prevention of diabetes and mechanism thereof: experiment with non-obese diabetic mice].
Zhang S; Yan X; Zhou PC; Huang C; Yang L; Li X; Lin J; Zhou ZG
Zhonghua Yi Xue Za Zhi; 2008 Feb; 88(8):568-72. PubMed ID: 18649776
[TBL] [Abstract][Full Text] [Related]
18. Systemic administration of multipotent mesenchymal stromal cells reverts hyperglycemia and prevents nephropathy in type 1 diabetic mice.
Ezquer FE; Ezquer ME; Parrau DB; Carpio D; Yañez AJ; Conget PA
Biol Blood Marrow Transplant; 2008 Jun; 14(6):631-40. PubMed ID: 18489988
[TBL] [Abstract][Full Text] [Related]
19. AEB-071 has minimal impact on onset of autoimmune diabetes in NOD mice.
Merani S; Edgar RL; Toso C; Emamaullee J; Thiesen A; Shapiro AM
Autoimmunity; 2009 Mar; 42(3):242-8. PubMed ID: 19301207
[TBL] [Abstract][Full Text] [Related]
20. [Inhibition of islet beta cell apoptosis and prevention diabetes by subcutaneous administration of insulin in NOD mice].
Jiang TJ; Zhou ZG; Su H
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2006 Aug; 31(4):499-504. PubMed ID: 16951506
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
